As of 2025-10-18, the Relative Valuation of Biogen Inc (BIIB) is 171.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 143.00 USD, the upside of Biogen Inc based on Relative Valuation is 20.2%.
The range of the Relative Valuation is 142.75 - 222.03 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 16.5x | 15.8x |
| Forward P/E multiples | 12.1x - 18.8x | 15.2x |
| Fair Price | 142.75 - 222.03 | 171.87 |
| Upside | -0.2% - 55.3% | 20.2% |
| Date | P/E |
| 2025-10-17 | 13.70 |
| 2025-10-16 | 13.63 |
| 2025-10-15 | 13.76 |
| 2025-10-14 | 13.92 |
| 2025-10-13 | 13.86 |
| 2025-10-10 | 14.04 |
| 2025-10-09 | 14.33 |
| 2025-10-08 | 14.46 |
| 2025-10-07 | 14.58 |
| 2025-10-06 | 14.76 |
| 2025-10-03 | 15.32 |
| 2025-10-02 | 14.87 |
| 2025-10-01 | 14.77 |
| 2025-09-30 | 13.42 |
| 2025-09-29 | 13.27 |
| 2025-09-26 | 13.16 |
| 2025-09-25 | 13.00 |
| 2025-09-24 | 13.19 |
| 2025-09-23 | 13.34 |
| 2025-09-22 | 13.47 |
| 2025-09-19 | 13.65 |
| 2025-09-18 | 13.78 |
| 2025-09-17 | 13.88 |
| 2025-09-16 | 13.76 |
| 2025-09-15 | 13.73 |
| 2025-09-12 | 13.88 |
| 2025-09-11 | 14.26 |
| 2025-09-10 | 13.66 |
| 2025-09-09 | 13.76 |
| 2025-09-08 | 13.54 |
| 2025-09-05 | 13.48 |
| 2025-09-04 | 13.41 |
| 2025-09-03 | 13.57 |
| 2025-09-02 | 13.38 |
| 2025-08-29 | 12.67 |
| 2025-08-28 | 12.71 |
| 2025-08-27 | 13.06 |
| 2025-08-26 | 13.10 |
| 2025-08-25 | 13.06 |
| 2025-08-22 | 13.34 |
| 2025-08-21 | 13.33 |
| 2025-08-20 | 13.31 |
| 2025-08-19 | 13.30 |
| 2025-08-18 | 13.02 |
| 2025-08-15 | 13.28 |
| 2025-08-14 | 12.93 |
| 2025-08-13 | 12.95 |
| 2025-08-12 | 12.35 |
| 2025-08-11 | 12.26 |
| 2025-08-08 | 12.52 |